216 related articles for article (PubMed ID: 16405538)
1. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.
Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Haagsma EB; Kuipers EJ; Janssen HL
Am J Gastroenterol; 2006 Jan; 101(1):83-90. PubMed ID: 16405538
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
Ganger DR; Klapman JB; McDonald V; Matalon TA; Kaur S; Rosenblate H; Kane R; Saker M; Jensen DM
Am J Gastroenterol; 1999 Mar; 94(3):603-8. PubMed ID: 10086638
[TBL] [Abstract][Full Text] [Related]
3. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.
Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Hopmans JA; Haagsma EB; van Hoek B; Hansen BE; Rosendaal FR; Janssen HL
Hepatology; 2004 Feb; 39(2):500-8. PubMed ID: 14768004
[TBL] [Abstract][Full Text] [Related]
4. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
Opitz T; Buchwald AB; Lorf T; Awuah D; Ramadori G; Nolte W
Z Gastroenterol; 2003 May; 41(5):413-8. PubMed ID: 12772054
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting.
Zeitoun G; Escolano S; Hadengue A; Azar N; El Younsi M; Mallet A; Boudet MJ; Hay JM; Erlinger S; Benhamou JP; Belghiti J; Valla D
Hepatology; 1999 Jul; 30(1):84-9. PubMed ID: 10385643
[TBL] [Abstract][Full Text] [Related]
6. Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis.
Mahmoud AE; Helmy AS; Billingham L; Elias E
Eur J Gastroenterol Hepatol; 1997 May; 9(5):485-9. PubMed ID: 9187882
[TBL] [Abstract][Full Text] [Related]
7. Changing perspectives in portal vein thrombosis.
Janssen HL
Scand J Gastroenterol Suppl; 2000; (232):69-73. PubMed ID: 11232496
[TBL] [Abstract][Full Text] [Related]
8. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries.
Panis Y; Belghiti J; Valla D; Benhamou JP; Fékété F
Surgery; 1994 Mar; 115(3):276-81. PubMed ID: 8128351
[TBL] [Abstract][Full Text] [Related]
9. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India.
Bhattacharyya M; Makharia G; Kannan M; Ahmed RP; Gupta PK; Saxena R
Am J Clin Pathol; 2004 Jun; 121(6):844-7. PubMed ID: 15198356
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of severe Budd-Chiari syndrome.
Xu PQ; Dang XW
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):525-8. PubMed ID: 14627513
[TBL] [Abstract][Full Text] [Related]
11. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India.
Mohanty D; Shetty S; Ghosh K; Pawar A; Abraham P
Hepatology; 2001 Oct; 34(4 Pt 1):666-70. PubMed ID: 11584361
[TBL] [Abstract][Full Text] [Related]
12. Acute Budd-Chiari syndrome with liver failure: the experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt.
Kavanagh PM; Roberts J; Gibney R; Malone D; Hegarty J; McCormick PA
J Gastroenterol Hepatol; 2004 Oct; 19(10):1135-9. PubMed ID: 15377290
[TBL] [Abstract][Full Text] [Related]
13. [Portal vein thrombosis: causes and treatment].
Janssen HL; van Buuren HR; Leebeek FW; Schalm SW
Ned Tijdschr Geneeskd; 1999 Oct; 143(41):2037-41. PubMed ID: 10560543
[TBL] [Abstract][Full Text] [Related]
14. Mesenteric and portal vein thrombosis: treated with early initiation of anticoagulation.
Joh JH; Kim DI
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):204-8. PubMed ID: 15649730
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of expandable venous stents for treatment of Budd-Chiari syndrome].
Wu X; Cao J; Wu X
Zhonghua Wai Ke Za Zhi; 1997 Sep; 35(9):518-21. PubMed ID: 10678021
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of 1360 cases of Budd-Chiari syndrome: 20-year experience.
Xu PQ; Ma XX; Ye XX; Feng LS; Dang XW; Zhao YF; Zhang SJ; Zhao LS; Tang Z; Lu XB
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):391-4. PubMed ID: 15313675
[TBL] [Abstract][Full Text] [Related]
17. Management of severe Budd-Chiari syndrome: report of 147 cases.
Feng LS; Peng QP; Li K; Ma XX; Zhao YF; Ye XX; Xu PQ; Chen XP
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):522-5. PubMed ID: 15567737
[TBL] [Abstract][Full Text] [Related]
18. Treatment of membranous Budd-Chiari syndrome: analysis of 480 cases.
Xu PQ; Dang XW
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):73-6. PubMed ID: 14969842
[TBL] [Abstract][Full Text] [Related]
19. Management of Budd-Chiari syndrome.
Ruh J; Malagó M; Busch Y; Lang H; Paul A; Verhagen R; Broelsch CE
Dig Dis Sci; 2005 Mar; 50(3):540-6. PubMed ID: 15810639
[TBL] [Abstract][Full Text] [Related]
20. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients.
Ringe B; Lang H; Oldhafer KJ; Gebel M; Flemming P; Georgii A; Borst HG; Pichlmayr R
Hepatology; 1995 May; 21(5):1337-44. PubMed ID: 7737640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
